HSCT-TMA
Stories
-
Alexion posts results of Phase 3 ravulizumab trial in HSCT-TMA
The study enrolled 148 participants and completed primary data collection on September 19, 2025. Results were first posted on ClinicalTrials.gov on November 4, 2026.